 LAUSANNE, Switzerland, April 27, 2022 GLOBE NEWSWIRE -- AC Immune SA NASDAQ: ACIU, a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today announced that Company Management will participate in a Fireside chat and one-on-one investor meetings during the B.Riley Annual Neuro Ophthalmology Virtual Investor Conference, taking place virtually on April 27-28, 2022. 